Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004207 |
---|---|
Receipt number | R000005056 |
Scientific Title | A Phase II Study of Erlotinib monotherapy for patients with non-small cell lung cancer wihtout EGFR mutation |
Date of disclosure of the study information | 2010/09/17 |
Last modified on | 2012/08/01 10:40:31 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/09/14 23:09:53 | ||
2 | Update | 2011/03/23 11:40:41 | Key inclusion criteria |
|
3 | Update | 2012/01/25 14:17:39 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2012/03/14 11:35:11 | Last name of lead principal investigator |
|
5 | Update | 2012/08/01 10:40:31 | Results |